176 related articles for article (PubMed ID: 29606609)
1. Using 340B drug discounts to provide a financially sustainable medication discharge service.
Wu T; Williams C; Vranek K; Mattingly TJ
Res Social Adm Pharm; 2019 Jan; 15(1):114-116. PubMed ID: 29606609
[TBL] [Abstract][Full Text] [Related]
2. 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation. Final rule.
Health Resources and Services Administration, Department of Health and Human Services (HHS)
Fed Regist; 2017 Jan; 82(3):1210-30. PubMed ID: 28071875
[TBL] [Abstract][Full Text] [Related]
3. Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016.
Conti RM; Nikpay SS; Buntin MB
JAMA Netw Open; 2019 Oct; 2(10):e1914141. PubMed ID: 31664442
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Legislative Reform to Protect the Integrity of the 340B Drug Discount Program.
Zeta LM
Food Drug Law J; 2015; 70(4):481-99, i. PubMed ID: 26827389
[TBL] [Abstract][Full Text] [Related]
5. 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation. Final rule; further delay of effective date.
Health Resources and Services Administration, HHS
Fed Regist; 2017 May; 82(96):22893-5. PubMed ID: 28574239
[TBL] [Abstract][Full Text] [Related]
6. The 340B discount program: outpatient prescription dispensing patterns through contract pharmacies in 2012.
Clark BL; Hou J; Chou CH; Huang ES; Conti R
Health Aff (Millwood); 2014 Nov; 33(11):2012-7. PubMed ID: 25367997
[TBL] [Abstract][Full Text] [Related]
7. Estimated Changes in Manufacturer and Health Care Organization Revenue Following List Price Reductions for Hepatitis C Treatments.
Dickson S; Reynolds I
JAMA Netw Open; 2019 Jul; 2(7):e196541. PubMed ID: 31276176
[TBL] [Abstract][Full Text] [Related]
8. Specialty Drug Price Trends in the Federal 340B Drug Discount Program.
Lee CH; Chang J; McCombs J
J Manag Care Spec Pharm; 2019 Feb; 25(2):178-187. PubMed ID: 30698090
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of the 340B Drug Pricing Program: A Scoping Review.
Knox RP; Wang J; Feldman WB; Kesselheim AS; Sarpatwari A
JAMA Health Forum; 2023 Nov; 4(11):e233716. PubMed ID: 37991784
[TBL] [Abstract][Full Text] [Related]
10. The 340B drug discount program: hospitals generate profits by expanding to reach more affluent communities.
Conti RM; Bach PB
Health Aff (Millwood); 2014 Oct; 33(10):1786-92. PubMed ID: 25288423
[TBL] [Abstract][Full Text] [Related]
11. Examining the Benefits of the 340b Drug Discount Program.
Gerlach J; McSweeney S; Swearingen A; Coustasse A
Health Care Manag (Frederick); 2018; 37(3):225-231. PubMed ID: 29901471
[TBL] [Abstract][Full Text] [Related]
12. Impact of the 340B Pharmacy Program on Services and Supports for Persons Served by Hemophilia Treatment Centers in the United States.
Malouin RA; Mckernan L; Forsberg A; Cheng D; Drake J; McLaughlin K; Trujillo M
Matern Child Health J; 2018 Sep; 22(9):1240-1246. PubMed ID: 29948762
[TBL] [Abstract][Full Text] [Related]
13. The 340b Program, Contract Pharmacies, Hospitals, and Patients: An Evolving Relationship Impacting Health Care Delivery.
Ruley M; Belcher M; Sayre H; Coustasse A
Health Care Manag (Frederick); 2019; 38(4):311-321. PubMed ID: 31663869
[TBL] [Abstract][Full Text] [Related]
14. Development of a metrics dashboard for monitoring involvement in the 340B Drug Pricing Program.
Karralli R; Tipton J; Dumitru D; Scholz L; Masilamani S
Am J Health Syst Pharm; 2015 Sep; 72(17):1489-95. PubMed ID: 26294243
[TBL] [Abstract][Full Text] [Related]
15. Consequences of the 340B Drug Pricing Program.
Desai S; McWilliams JM
N Engl J Med; 2018 Feb; 378(6):539-548. PubMed ID: 29365282
[TBL] [Abstract][Full Text] [Related]
16. Budgetary impact analysis of a primary care-based hepatitis C treatment program: Effects of 340B Drug Pricing Program.
Jones EA; Linas BP; Truong V; Burgess JF; Lasser KE
PLoS One; 2019; 14(3):e0213745. PubMed ID: 30870475
[TBL] [Abstract][Full Text] [Related]
17. Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation. Final rule; further delay of effective date.
Health Resources and Services Administration, HHS
Fed Regist; 2017 Sep; 82(188):45511-4. PubMed ID: 28990743
[TBL] [Abstract][Full Text] [Related]
18. A comparison of medication access services at 340B and non-340B hospitals.
Rana I; von Oehsen W; Nabulsi NA; Sharp LK; Donnelly AJ; Shah SD; Stubbings J; Durley SF
Res Social Adm Pharm; 2021 Nov; 17(11):1887-1892. PubMed ID: 33846100
[TBL] [Abstract][Full Text] [Related]
19. 340B-Where Do We Go From Here?
Kishore S; Nayak RK; Kesselheim AS
JAMA; 2023 Aug; 330(7):593-594. PubMed ID: 37505512
[TBL] [Abstract][Full Text] [Related]
20. US Hospital Service Availability and New 340B Program Participation.
Owsley KM; Hasnain-Wynia R; Rooks RN; Tung GJ; Mays GP; Lindrooth RC
JAMA Health Forum; 2024 May; 5(5):e240833. PubMed ID: 38700853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
